KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Operating Leases (2019 - 2025)

Jazz Pharmaceuticals has reported Operating Leases over the past 7 years, most recently at $65.2 million for Q4 2025.

  • Quarterly Operating Leases rose 67.37% to $65.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.2 million through Dec 2025, up 67.37% year-over-year, with the annual reading at $65.2 million for FY2025, 67.37% up from the prior year.
  • Operating Leases was $65.2 million for Q4 2025 at Jazz Pharmaceuticals, up from $53.4 million in the prior quarter.
  • Over five years, Operating Leases peaked at $177.1 million in Q2 2021 and troughed at $38.8 million in Q1 2025.
  • The 5-year median for Operating Leases is $69.4 million (2024), against an average of $75.7 million.
  • Biggest five-year swings in Operating Leases: crashed 56.03% in 2022 and later surged 67.37% in 2025.
  • Tracing JAZZ's Operating Leases over 5 years: stood at $87.2 million in 2021, then fell by 17.62% to $71.8 million in 2022, then dropped by 17.56% to $59.2 million in 2023, then plummeted by 34.25% to $38.9 million in 2024, then soared by 67.37% to $65.2 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $65.2 million, $53.4 million, and $55.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.